2022
DOI: 10.1073/pnas.2118654119
|View full text |Cite
|
Sign up to set email alerts
|

Precautions for study design and data interpretation of clinical metabolomics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
4
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 5 publications
0
4
0
Order By: Relevance
“…Second, Zheng et al (2) note the age difference between test subjects with dementia and those who served as controls in our study (3). It is possible that aging increases the risk of neurodegenerative diseases (6).…”
mentioning
confidence: 64%
See 3 more Smart Citations
“…Second, Zheng et al (2) note the age difference between test subjects with dementia and those who served as controls in our study (3). It is possible that aging increases the risk of neurodegenerative diseases (6).…”
mentioning
confidence: 64%
“…Accurate, nontargeted, comprehensive analysis of metabolites provides essential information about cutting-edge clinical questions (1). Zheng et al (2) question the legitimacy of our recent discovery of dementia markers using whole-blood metabolomics (3).…”
mentioning
confidence: 99%
See 2 more Smart Citations